gadolinium has been researched along with Central Nervous System Diseases in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (10.00) | 18.7374 |
1990's | 21 (52.50) | 18.2507 |
2000's | 8 (20.00) | 29.6817 |
2010's | 3 (7.50) | 24.3611 |
2020's | 4 (10.00) | 2.80 |
Authors | Studies |
---|---|
Barkhof, F; Brouwer, I; Bø, L; Kerklingh, E; Lie, IA; Myhr, KM; Torkildsen, Ø; van Nederpelt, DR; Vrenken, H; Wesnes, K | 1 |
Aboye, AG; Balcha, TE; Woldeyohannes, AM | 1 |
Barnett, MH; Graham, SL; Klistorner, A; Klistorner, S; Parratt, J; Yiannikas, C | 1 |
Amoura, Z; Cohen Aubart, F; Galanaud, D; Haroche, J; Pineton de Chambrun, M | 1 |
Angstwurm, K; Bohner, G; Hofmann, J; Otto, C; Rothenfusser-Korber, E; Ruprecht, K; Scheibe, F; Vollrath, B; Wengert, O | 1 |
Butler, A; Guandalini, M; Mandelstam, S | 1 |
Brochet, B; Dousset, V; Petry, KG; Tourdias, T | 1 |
Hazama, Y; Ishibashi, M; Kimura, N; Kimura, Y; Kumamoto, T; Takahashi, Y | 1 |
Batocchi, AP; Caggiula, M; Colitto, F; Colosimo, C; Guzzetta, F; Lo Monaco, M; Mariotti, P; Tonali, PA | 1 |
Essig, M | 1 |
Banwell, B; Jeffery, D; Ness, JM; Schwid, S; Shroff, M; Weinstock-Guttman, B | 1 |
Lalwani, AK; Mallur, PS | 1 |
Akeson, P; Haugen, I; Holtås, S; Jonsson, E | 1 |
Nelson, KL; Runge, VM | 1 |
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ | 1 |
Christensen, T; Lundorf, E; Svaland, MG | 1 |
Altman, NR; Ball, WS; Byrd, SE; Dietrich, RB; Drayer, BP; Morgan, FW; Nadel, SN; Nelson, MD; Prenger, EC; Zimmerman, RA | 1 |
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W | 1 |
Adams, D; Carlier, R; Doyon, D; Erdem, E; Idir, AB; Masnou, PO; Moulonguet, A | 1 |
Aisen, AM; Bradley, WG; Brant-Zawadzki, M; Dreisbach, JN; Haughton, VM; Kumar, AJ; Maravilla, KR; McNamara, MT; Sze, G; Weinreb, JC | 1 |
Atlas, SW | 1 |
Byrd, SE; Darling, CF; Wilczynski, MA | 1 |
Ekholm, S; Fagerlund, M; Holtås, S; Isberg, B; Jonsson, E; Lindell, D; Lindén, B; Sandvik, L; Sjöberg, S; Thuomas , KA; Tollesson, PO | 1 |
Gordon, P; Hugo, F; Lundby, B | 1 |
Colosimo, C; Manfredi, R; Tartaglione, T | 1 |
Kirchin, MA; Pirovano, GP; Spinazzi, A | 1 |
Baker, JF; Barr, R; Barr, W; Barron, B; Free, R; Gazelle, GS; Lambrecht, LJ; Maravilla, KR; Pierro, JA; Seltzer, S; Stevens, GR; Swan, SK; Tucker, RM | 1 |
Stevens, JM | 1 |
Brunberg, JA; Grodd, W; Grossman, RI; Haughton, VM; Heindel, W; Hunter, G; Jinkins, JR; Kanal, E; Kristy, RM; Kuhn, MJ; Lee, D; Leeds, N; Maravilla, K; Provenzale, JM; Ramsey, R; Rubin, DL; Simon, J; Stevens, GR; Sze, G; Truwit, C; Tu, R; Wippold, FJ; Zelch, J | 1 |
Cérez, D; Frédy, D; Méary, E; Meder, J; Zylberberg, F | 1 |
Jinkins, JR; Muroff, LR; Runge, VM | 1 |
Brant-Zawadzki, M | 1 |
Bradley, WG; Brant-Zawadzki, MN; Carvlin, MJ; Dean, BL; DeSimone, DN; Dillon, WP; Drayer, BP; Flanders, AE; Harms, SE; Runge, VM | 1 |
Gelblum, DY; Runge, VM | 1 |
Baierl, P; Bauer, WM; Fendel, H; Förster, C; Haustein, J; Mühlsteffen, A; Niendorf, HP | 1 |
Sze, G | 1 |
Carollo, BR; Gelblum, DY; Nelson, KL; Runge, VM; Wolf, CR | 1 |
Freeman, MW; Kessler, RM; Partain, CL; Powers, TA; Robertson, RH; Whelan, HT; Wyatt, SH | 1 |
Iio, M; Kono, T; Mano, I; Terao, H; Tsuchida, T; Yoshida, H | 1 |
Iio, M | 1 |
12 review(s) available for gadolinium and Central Nervous System Diseases
Article | Year |
---|---|
[A case of neurosarcoidosis with swelling and gadolinium enhancement of spinal nerve roots on magnetic resonance imaging].
Topics: Aged, 80 and over; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Sarcoidosis; Spinal Nerve Roots | 2011 |
Clinical experience with MultiHance in CNS imaging.
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Randomized Controlled Trials as Topic; Sensitivity and Specificity | 2003 |
Basic principles of MR contrast.
Topics: Central Nervous System Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid | 1995 |
Rationale and clinical indications for contrast agents in MR imaging of the brain and spine.
Topics: Brain; Central Nervous System Diseases; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Reference Values; Sensitivity and Specificity; Spine | 1993 |
Contrast enhancement issues in the MR evaluation of the central nervous system.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds | 1997 |
Gadobenate dimeglumine (Gd-BOPTA). An overview.
Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds | 1998 |
The spine and spinal cord.
Topics: Central Nervous System Diseases; Gadolinium; Humans; Magnetic Resonance Imaging; Myelography; Pentetic Acid; Spinal Cord Diseases; Spinal Diseases; Vascular Diseases | 1990 |
[MRI aspects of central nervous system sarcoidosis].
Topics: Aftercare; Central Nervous System Diseases; Diagnosis, Differential; Gadolinium; Humans; Magnetic Resonance Imaging; Radioisotopes; Reproducibility of Results; Sarcoidosis; Sensitivity and Specificity; Treatment Outcome | 2001 |
Central nervous system: review of clinical use of contrast media.
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds | 2001 |
Pitfalls of contrast-enhanced imaging in the nervous system.
Topics: Central Nervous System Diseases; Central Nervous System Neoplasms; Contrast Media; Costs and Cost Analysis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid | 1990 |
Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
Topics: Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Spinal Diseases | 1989 |
13 trial(s) available for gadolinium and Central Nervous System Diseases
Article | Year |
---|---|
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord Diseases | 1994 |
Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
Topics: Adolescent; Brain; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Infant; Magnetic Resonance Imaging; Male; Neurologic Examination; Organometallic Compounds; Spinal Cord | 1993 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1993 |
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
Topics: Adolescent; Central Nervous System; Central Nervous System Diseases; Child; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds | 1993 |
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Drug Tolerance; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Surveys and Questionnaires | 1996 |
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety | 1996 |
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety | 1999 |
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).
Topics: Adult; Aged; Brain; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Organometallic Compounds; Spinal Cord | 2000 |
Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Spinal Cord | 1991 |
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid | 1988 |
15 other study(ies) available for gadolinium and Central Nervous System Diseases
Article | Year |
---|---|
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Topics: Atrophy; Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Gray Matter; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases; Prospective Studies; Reproducibility of Results | 2022 |
Imaging Findings of Concomitant Pulmonary and Central Nervous System Sarcoidosis: A Case Report.
Topics: Brain; Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Lung; Male; Middle Aged; Sarcoidosis | 2022 |
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy.
Topics: Atrophy; Central Nervous System Diseases; Choroid Plexus; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurodegenerative Diseases | 2022 |
The eclipse sign as a radiological presentation of neurosarcoidosis.
Topics: Adult; Brain; Central Nervous System Diseases; Female; Gadolinium; Granuloma; Humans; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; Sarcoidosis | 2020 |
Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.
Topics: Adult; Aged; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meninges; Middle Aged; PubMed; Retrospective Studies; Sarcoidosis; Statistics as Topic; Young Adult | 2013 |
Spectrum of imaging appearances in Australian children with central nervous system hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Atrophy; Australia; Brain; Central Nervous System Diseases; Child; Child, Preschool; Diffusion Magnetic Resonance Imaging; Female; Gadolinium; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Optic Nerve; Retrospective Studies; Subdural Space; Treatment Outcome | 2014 |
[Magnetic resonance imaging of central nervous system inflammation].
Topics: Animals; Central Nervous System Diseases; Gadolinium; Humans; Inflammation; Lysophosphatidylcholines; Magnetic Resonance Imaging; Rats; Sensitivity and Specificity | 2009 |
Multiphasic demyelinating disease involving central and peripheral nervous system in a child.
Topics: Central Nervous System Diseases; Child; Demyelinating Diseases; Disease Progression; Encephalomyelitis, Acute Disseminated; Gadolinium; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Peripheral Nervous System Diseases; Recurrence; Remission Induction | 2003 |
MRI features of pediatric multiple sclerosis.
Topics: Adult; Central Nervous System Diseases; Child; Contrast Media; Encephalomyelitis, Acute Disseminated; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Nerve Fibers, Myelinated; Pediatrics; Predictive Value of Tests; Prognosis | 2007 |
Fluctuating corticosteroid-responsive auditory neuropathy/dyssynchrony is suggestive of central nervous system pathology.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Audiology; Audiometry, Pure-Tone; Central Nervous System Diseases; Child; Cochlear Nerve; Cyclophosphamide; Evoked Potentials, Auditory, Brain Stem; Female; Gadolinium; Hearing Loss, Unilateral; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Myelin Sheath; Speech Discrimination Tests; Vestibulocochlear Nerve Diseases | 2007 |
Gadolinium-enhanced MRI in central nervous system Behçet's disease.
Topics: Adult; Behcet Syndrome; Brain; Central Nervous System Diseases; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, X-Ray Computed | 1993 |
Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.
Topics: Adolescent; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms | 1990 |
New applications of MR contrast agents in neuroradiology.
Topics: Bone Diseases; Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meninges; Meningitis; Skull; Spinal Cord Diseases; Spinal Diseases | 1990 |
[The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid | 1987 |
[Contrast-enhanced MRI and contrast medium development].
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid | 1987 |